June 16, 2026 FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
June 16, 2026 BreachRx Appoints Phil Venables to Board of Directors as AI Attack Era Redefines Enterprise Incident Response
